1. Whole-body MRI versus an [F-18]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin's lymphoma
- Author
-
Bart de Keizer, Federico Verzegnassi, Suzanne Spijkers, Goya Enríquez, Claudio Granata, Auke Beishuizen, Marrie C.A. Bruin, Thomas C. Kwee, Constantino Sábado, Elka Miller, Rutger A.J. Nievelstein, Annemieke S. Littooij, Nelleke Tolboom, Charlotte de Lange, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Institut Català de la Salut, [Spijkers S] Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht/Wilhelmina Children’s Hospital, Utrecht University, Utrecht, The Netherlands. [Littooij AS, Tolboom N] Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht/Wilhelmina Children’s Hospital, Utrecht, The Netherlands. Princess Máxima Centre for Paediatric Oncology, Utrecht, The Netherlands. [Kwee TC] Department of Radiology, Medical Imaging Centre, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands. [Beishuizen A] Princess Máxima Centre for Paediatric Oncology, Utrecht, The Netherlands. Department of Paediatric Oncology/Haematology, Erasmus Medical Centre-Sophia Children’s Hospital, Rotterdam, The Netherlands. [Bruin MCA] Princess Máxima Centre for Paediatric Oncology, Utrecht, The Netherlands. [Enríquez G] Servei de Radiologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Sábado C] Servei d’Oncologia i Hematologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, and Pediatrics
- Subjects
medicine.medical_specialty ,Hodgkin disease ,Diffusion magnetic resonance imaging ,PET/CT ,Concordance ,Whole body imaging ,THERAPY ,DISEASE ,Cohen's kappa ,Medicine ,Radiology, Nuclear Medicine and imaging ,Hodgkin, Malaltia de - Imatgeria ,Child ,MASSES ,Other subheadings::Other subheadings::/diagnostic imaging [Other subheadings] ,Neuroradiology ,Whole-body imaging ,Pediatria ,medicine.diagnostic_test ,business.industry ,Positron emission tomography computed tomography ,Otros calificadores::Otros calificadores::/diagnóstico por imagen [Otros calificadores] ,Interventional radiology ,General Medicine ,Hodgkin's lymphoma ,medicine.disease ,observer variation ,neoplasias::neoplasias por tipo histológico::linfoma::enfermedad de Hodgkin [ENFERMEDADES] ,Lymphoma ,Response assessment ,Imatgeria per ressonància magnètica ,Radiology ,business ,Neoplasms::Neoplasms by Histologic Type::Lymphoma::Hodgkin Disease [DISEASES] - Abstract
Objectives To compare WB-MRI with an [18F]FDG-PET/CT-based reference for early response assessment and restaging in children with Hodgkin’s lymphoma (HL). Methods Fifty-one children (ages 10–17) with HL were included in this prospective, multicentre study. All participants underwent WB-MRI and [18F]FDG-PET/CT at early response assessment. Thirteen of the 51 patients also underwent both WB-MRI and [18F]FDG-PET/CT at restaging. Two radiologists independently evaluated all WB-MR images in two separate readings: without and with DWI. The [18F]FDG-PET/CT examinations were evaluated by a nuclear medicine physician. An expert panel assessed all discrepancies between WB-MRI and [18F]FDG-PET/CT to derive the [18F]FDG-PET/CT-based reference standard. Inter-observer agreement for WB-MRI was calculated using kappa statistics. Concordance, PPV, NPV, sensitivity and specificity for a correct assessment of the response between WB-MRI and the reference standard were calculated for both nodal and extra-nodal disease presence and total response evaluation. Results Inter-observer agreement of WB-MRI including DWI between both readers was moderate (κ 0.46–0.60). For early response assessment, WB-MRI DWI agreed with the reference standard in 33/51 patients (65%, 95% CI 51–77%) versus 15/51 (29%, 95% CI 19–43%) for WB-MRI without DWI. For restaging, WB-MRI including DWI agreed with the reference standard in 9/13 patients (69%, 95% CI 42–87%) versus 5/13 patients (38%, 95% CI 18–64%) for WB-MRI without DWI. Conclusions The addition of DWI to the WB-MRI protocol in early response assessment and restaging of paediatric HL improved agreement with the [18F]FDG-PET/CT-based reference standard. However, WB-MRI remained discordant in 30% of the patients compared to standard imaging for assessing residual disease presence. Key Points • Inter-observer agreement of WB-MRI including DWI between both readers was moderate for (early) response assessment of paediatric Hodgkin’s lymphoma. • The addition of DWI to the WB-MRI protocol in early response assessment and restaging of paediatric Hodgkin’s lymphoma improved agreement with the [18F]FDG-PET/CT-based reference standard. • WB-MRI including DWI agreed with the reference standard in respectively 65% and 69% of the patients for early response assessment and restaging.
- Published
- 2021